Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Activity of lansoprazole against Helicobacter pylori.

× No keyword cloud information.

17 in total

1. Helicobacter pylori gastritis and epithelial cell proliferation in patients with reflux oesophagitis after treatment with lansoprazole.

Authors: A E Berstad; J G Hatlebakk; H Maartmann-Moe; A Berstad; P Brandtzaeg
Journal: Gut Date: 1997-12 Impact factor: 23.059

2. Antibacterial properties of lansoprazole alone and in combination with antimicrobial agents against Helicobacter pylori.

Authors: M Nakao; M Tada; K Tsuchimori; M Uekata
Journal: Eur J Clin Microbiol Infect Dis Date: 1995-05 Impact factor: 3.267

Review 3. Helicobacter pylori: the place of the new macrolides in the eradication of the bacteria in peptic ulcer disease.

Authors: A Burette; Y Glupczynski
Journal: Infection Date: 1995 Impact factor: 3.553

Review 4. Gastroenterology--I: Gastroduodenal disease and Helicobacter pylori.

Authors: M C Bateson
Journal: Postgrad Med J Date: 1994-08 Impact factor: 2.401

5. In vitro activity of rifaximin against Helicobacter pylori.

Authors: F Mégraud; F Bouffant; C Camou Juncas
Journal: Eur J Clin Microbiol Infect Dis Date: 1994-02 Impact factor: 3.267

Review 6. Potent gastric acid inhibition in Helicobacter pylori eradication.

Authors: Javier P Gisbert
Journal: Drugs Date: 2005 Impact factor: 9.546

Review 7. Diagnosis of Helicobacter pylori: what should be the gold standard?

Authors: Saurabh Kumar Patel; Chandra Bhan Pratap; Ashok Kumar Jain; Anil Kumar Gulati; Gopal Nath
Journal: World J Gastroenterol Date: 2014-09-28 Impact factor: 5.742

8. Effect of eradication of Helicobacter pylori infection on gastric epithelial cell proliferation.

Authors: R J Cahill; H Xia; C Kilgallen; S Beattie; H Hamilton; C O'Morain
Journal: Dig Dis Sci Date: 1995-08 Impact factor: 3.199

Review 9. Lansoprazole. A review of its pharmacodynamic and pharmacokinetic properties and its therapeutic efficacy in acid-related disorders.

Authors: L B Barradell; D Faulds; D McTavish
Journal: Drugs Date: 1992-08 Impact factor: 9.546

10. Metronidazole resistance reduces efficacy of triple therapy and leads to secondary clarithromycin resistance.

Authors: M J Buckley; H X Xia; D M Hyde; C T Keane; C A O'Morain
Journal: Dig Dis Sci Date: 1997-10 Impact factor: 3.199